Corona Remedies Clarifies Volume Increase is Market Driven

Corona Remedies Ltd has responded to a clarification request from the BSE regarding a recent increase in trading volume. The company stated that it is compliant with SEBI regulations and has promptly disclosed all material information. They confirmed there is no undisclosed price-sensitive information or impending corporate action. The increase in share volume is attributed purely to market-driven factors. Corona Remedies reiterated its commitment to ongoing compliance with disclosure requirements.